Inflammatory Challenge and Fear

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of California, San Francisco

About this trial

The goal of this study is to learn if short-term changes in the immune system alter how we process information and experience fear. The main questions it aims to answer are:

Do people who receive typhoid vaccine respond differently than those who receive a placebo saline vaccine? Do people who receive typhoid vaccine experience changes in how they think and feel?

Participants will:

Attend four appointments at the San Francisco VA Health Care System;

Receive typhoid vaccine or placebo at one of the visits;

Have their physiological responding measured while listening to sounds;

Complete questionnaires and psychological tests.

Eligibility criteria

Qualifiers

Aged 18-60 years old

Trauma Exposed

Current PTSD/No history of PTSD

Disqualifiers

Contraindications to typhoid vaccine

Conditions associated with inflammation

Pregnancy or plans to become pregnant in next three months

Trial design

Treatments tested in this trial

  • Typhoid VI Polysaccharide Vaccine Injectable Solution
  • Saline Placebo (0.5mL injection)

Treatment groups

288 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

Northern California Institute of Research and Education

Collaborator

San Francisco Veterans Affairs Medical Center

Collaborator